Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pharmaceutical Research

• Publication date

  2018-01-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11095-017-2279-zPMID 29294189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".

  2016influential reference
• Paliperidone microemulsion for nose-to-brain targeted drug delivery system: pharmacodynamic and pharmacokinetic evaluation

  2016cited by this paper
• Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration

  2016cited by this paper
• Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.

  2016influential reference
• Transcutol® (Diethylene Glycol Monoethyl Ether): A Potential Penetration Enhancer

  2015cited by this paper
• Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization

  2015influential reference
• Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery

  2015cited by this paper
• Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.

  2014cited by this paper
• Current approaches to enhance CNS delivery of drugs across the brain barriers

  2014influential reference
• Intranasal delivery of streptomycin sulfate (STRS) loaded solid lipid nanoparticles to brain and blood.

  2014cited by this paper
• Analytical Challenges and Regulatory Requirements for Nasal Drug Products in Europe and the U.S.

  2014cited by this paper
• Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.

  2013cited by this paper
• Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.

  2012cited by this paper
• Intranasal clobazam delivery in the treatment of status epilepticus.

  2011cited by this paper
• Mucoadhesive chitosan microspheres of carvedilol for nasal administration

  2010cited by this paper
• Strategy for effective brain drug delivery.

  2010influential reference
• Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.

  2009cited by this paper
• Intranasal drug delivery: how, why and what for?

  2009cited by this paper
• Blood-brain barrier delivery.

  2007cited by this paper
• Neurological Disorders: Public Health Challenges

  2007cited by this paper
• Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate.

  2006cited by this paper
• Direct Nose-to-Brain Transfer of Morphine After Nasal Administration to Rats

  2006cited by this paper
• Nasal drug delivery: new developments and strategies.

  2002cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• P-Glycoprotein, a gatekeeper in the blood-brain barrier.

  1999cited by this paper
• Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat.

  1996cited by this paper
• Physics and Radiobiology of Nuclear Medicine

  1993cited by this paper

• Novel Intranasal Fisetin-Loaded Mucoadhesive Microemulsion for Schizophrenia Management: A Nanotherapeutic Approach to Enhance Brain Bioavailability and Improved Efficacy.

  2025cites this paper
• Can nanoparticle-based intranasal delivery systems revolutionize treatment of central nervous system diseases?

  2025cites this paper
• Gamma scintigraphy in sensing drug delivery systems

  2024cites this paper
• An Update on the Potential of Nanocarriers for Intranasal Delivery

  2024cites this paper
• Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems

  2024cites this paper
• A review of chitosan polysaccharides: Neuropharmacological implications and tissue regeneration.

  2024cites this paper
• Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies.

  2023cites this paper
• Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management

  2023cites this paper
• KLVFF Conjugated Curcumin Microemulsion-Based Hydrogel for Transnasal Route: Formulation Development, Optimization, Physicochemical Characterization, and Ex Vivo Evaluation

  2023cites this paper
• Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

  2022cites this paper
• Sensitive RP-HPLC Method of Rivastigmine for Applicative Quantification of Nanostructured Lipid Carriers

  2022cites this paper
• A SYSTEMATIC OVERVIEW ON NOSE TO BRAIN DRUG DELIVERY SYSTEM IN TREATMENT OF NEURODEGENERATIVE DISORDERS

  2022cites this paper
• Liquid Formulations Based on Ionic Liquids in Biomedicine

  2022cites this paper
• Recent nanoscale carriers for therapy of Alzheimer's disease: current strategies and perspectives.

  2022cites this paper
• Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer’s Drugs

  2022cites this paper
• Intranasal delivery of lipid-based nanosystems as a promising approach for brain targeting of the new-generation antiepileptic drug perampanel.

  2022cites this paper
• Surface Modification of Curcumin Microemulsions by Coupling of KLVFF Peptide: A Prototype for Targeted Bifunctional Microemulsions

  2022cites this paper
• Microemulsion as a promising carrier for nose to brain delivery: journey since last decade

  2021cites this paper
• Comparative evaluation of intranasally delivered quetiapine loaded mucoadhesive microemulsion and polymeric nanoparticles for brain targeting: pharmacokinetic and gamma scintigraphy studies

  2021cites this paper
• Microemulsion-Based Media in Nose-to-Brain Drug Delivery

  2021cites this paper
• Efficient Treatment of Experimental Cerebral Malaria by an Artemisone-SMEDDS System: Impact of Application Route and Dosing Frequency

  2021cites this paper
• Nanotechnologies for intranasal drug delivery: an update of literature

  2021cites this paper
• Progress in nasal drug delivery systems.

  2021cites this paper
• Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.

  2021cites this paper
• Nanoparticlized System: Promising Approach for the Management of Alzheimer's Disease through Intranasal Delivery.

  2020cites this paper
• Natural Polysaccharide Carriers in Brain Delivery: Challenge and Perspective

  2020cites this paper
• Effect of nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D skin cancer models.

  2020cites this paper
• Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems

  2020cites this paper
• Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System

  2020cites this paper
• Biodistribution and amyloid beta induced cell line toxicity study of intranasal Rivastigmine microemulsion enriched with Fish Oil and Butter oil

  2020cites this paper
• Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders

  2020cites this paper
• Topical Delivery of Meloxicam using Liposome and Microemulsion Formulation Approaches

  2020cites this paper
• Nose-to-brain drug delivery

  2020cites this paper
• Nose to brain delivery of nanocarriers towards attenuation of demented condition.

  2020cites this paper
• Nose-to-Brain Delivery

  2019cites this paper
• Oral delivery of lycopene-loaded microemulsion for brain-targeting: preparation, characterization, pharmacokinetic evaluation and tissue distribution

  2019cites this paper
• A Nasal Temperature and pH Dual-Responsive In Situ Gel Delivery System Based on Microemulsion of Huperzine A: Formulation, Evaluation, and In Vivo Pharmacokinetic Study

  2019cites this paper
• Preparation, preliminary pharmacokinetics and brain tissue distribution of Tanshinone IIA and Tetramethylpyrazine composite nanoemulsions

  2019cites this paper
• Intranasal drug delivery: Novel delivery route for effective management of neurological disorders

  2019cites this paper
• Fabrication of an Ion-sensitive in situ Gel loaded with Nanostructured Lipid Carrier for Nose to Brain Delivery of Donepezil

  2018cites this paper
• Brain targeting of chitosan-based diazepam mucoadhesive microemulsions via nasal route: formulation optimization, characterization, pharmacokinetic and pharmacodynamic evaluation

  2018cites this paper